CNL Launches New Nuclear & Emerging Technologies (N2ET) Program to Accelerate Innovative, Next-Generation Technologies
02 Agosto 2024 - 3:11PM
Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear
science and technology organization, is pleased to announce the
launch of an exciting portfolio of work known as the New Nuclear
& Emerging Technologies (N2ET) program. N2ET is designed to
help fast-track promising research and technologies towards
commercialization and deployment. The new program is aimed at
facilitating collaboration between CNL and other pioneering
technology developers, as well as positioning CNL to direct funding
into promising technologies or ventures that align with its
mandate.
The N2ET program initially consolidates several
existing clean energy and health sciences projects into one
program, including CNL’s small modular reactor (SMR) siting
invitation; the Canadian Nuclear Research Initiative (CNRI); CNL’s
Clean Energy Demonstration, Innovation and Research (CEDIR) Park
project; the joint venture company, Actineer, recently launched by
CNL and ITM Isotope Technologies Munich SE (ITM) of Germany; and,
Fusion Fuel Cycles, Inc., a new joint venture recently announced
between CNL and Kyoto Fusioneering of Japan. Overall, N2ET is
expected to encompass research and technologies that include
nuclear energy, fusion, hydrogen and even renewables, as well as
health sciences, with a key focus on medical isotopes.
As its namesake indicates, the N2ET program
creates opportunities for emerging technologies to tap into
resources, including potential funding, designed to help move
innovative ideas through to technology and market readiness. A key
advantage in the formation of the N2ET program is the ability for
CNL to help promising technologies or companies that align with its
mandate.
“Over the past five years, CNL has made
meaningful progress in building and growing a broad portfolio of
projects that give ambitious companies better access to our
extensive technical resources, and which advance innovative
technologies to address real-world problems,” commented Dr. Stephen
Bushby, CNL’s Vice-President of Science and Technology. “We are now
consolidating these projects into N2ET, CNL’s new flagship program,
which will offer better consistency, focus and synergies across
these projects, and which also opens opportunities to better
collaborate with promising Canadian companies and technologies.
N2ET is the future of CNL, and it is already off to a tremendous
start.”
“AECL’s vision is to drive nuclear innovation
and to leverage science, technology and CNL’s expertise for the
benefit of Canada. It is proud to support CNL in launching the N2ET
program as it directly supports our vision. Canada’s nuclear sector
is poised for growth and the N2ET program is intended to assist and
encompass important opportunities for Canada at this critical
juncture,” said Grant Gardiner, AECL’s Executive Vice-President,
Strategy and Business Development.
Facts about CNL’s N2ET
Program
- The new N2ET program at CNL
encompasses a variety of existing projects within its clean energy
and health sciences programs, including:
- The SMR siting program, which
invites vendors to construct small modular reactor, fusion reactor,
or other advanced reactor demonstration units at one of the sites
that CNL manages on behalf of Atomic Energy of Canada Limited
(AECL).
- The CNRI program, which is designed
to accelerate the development and deployment of advanced reactor
designs, and which allows participants to optimize resources, share
technical knowledge and gain access to CNL’s expertise and unique
facilities.
- The CEDIR Park program, which
advances the science behind hybrid energy systems to better
understand how clean energy technologies can work together
alongside other renewable energy technologies.
- The launch of Actineer Inc., a new
joint venture company between CNL and ITM that is pursuing the
industrial scale production of Actinium-225, a promising new
medical isotope in the fight against cancer.
- The formation of Fusion Fuel Cycles
Inc., a joint venture between CNL and Kyoto Fusioneering, which
aims to develop and deploy deuterium-tritium (D-T) fusion fuel
cycle technologies.
- CNL’s support for projects under
the N2ET portfolio of activities over the last five years has
averaged $17 Million on an annual basis with variance based on
project demand; expectations are for further growth in the years
ahead.
- N2ET aligns with Vision 2030, CNL’s
corporate strategy, which organizes its activities into three
strategic priorities – restoring and protecting the environment,
advancing clean energy for today and tomorrow, and contributing to
the health of Canadians – that guides the company in pursuit of
next-generation solutions to address some of the nation’s biggest
challenges.
About CNL
As Canada’s premier nuclear science and
technology laboratory and working under the direction of Atomic
Energy of Canada Limited (AECL), CNL is a world leader in the
development of innovative nuclear science and technology products
and services. Guided by an ambitious corporate strategy known as
Vision 2030, CNL fulfills three strategic priorities of national
importance – restoring and protecting the environment, advancing
clean energy technologies, and contributing to the health of
Canadians.
By leveraging the assets owned by AECL, CNL also
serves as the nexus between government, the nuclear industry, the
broader private sector and the academic community. CNL works in
collaboration with these sectors to advance innovative Canadian
products and services towards real-world use, including carbon-free
energy, cancer treatments and other therapies, non-proliferation
technologies and waste management solutions.
To learn more about CNL, please visit
www.cnl.ca.
About Atomic Energy of Canada
Limited
Atomic Energy of Canada Limited (AECL) is a
federal Crown corporation with a mandate to drive nuclear
opportunities for Canada. Working through a government-owned /
contractor-operated (GoCo) model that is executed by its
contractor, Canadian Nuclear Laboratories, AECL enables nuclear
science and technology through its Chalk River
Laboratories, Canada’s largest research complex, and by
engaging with academia and private industry to advance nuclear
innovation. It is committed to advancing reconciliation with
Indigenous peoples. It also manages the Government
of Canada’s radioactive waste responsibilities. AECL
continues to own the intellectual property for the CANDU® reactor
technology and is accountable for deriving optimal benefit from
this technology for Canada.
Read more on AECL at www.aecl.ca.
CNL Contact:Philip KompassDirector, Corporate
Communications1-866-886-2325media@cnl.ca